01
Cash & equivalents increased 13.5%
Cash & equivalents changed +13.5% from the comparable as-filed period.
$119.4M→$135.5MComparable → current
· Pharmaceutical Preparations
RESEARCH SNAPSHOTEnliven Therapeutics, Inc.'s latest supported as-filed period reports interest income of $4.7M. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +13.5% from the comparable as-filed period.
Net income changed -28.2% from the comparable as-filed period.
Operating income changed -30.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
ELVN · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001882764-26-000007SEC ↗4Aug 19, 2026Period Aug 17, 20260001701247-26-000012SEC ↗4Aug 6, 2026Period Aug 4, 20260001865125-26-000004SEC ↗10-QAug 5, 2026Period Jun 30, 20260001193125-26-335155SEC ↗8-KAug 5, 2026Period Aug 5, 20260001193125-26-335101SEC ↗4Jul 21, 2026Period Jul 17, 20260001882764-26-000006SEC ↗4Jul 21, 2026Period Jul 17, 20260001701247-26-000011SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Research & development changed +34.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Stock-based compensation changed +80.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001536368-26-000007